Literature DB >> 1389084

Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type.

R F Zec1, E S Landreth, S K Vicari, E Feldman, J Belman, A Andrise, R Robbs, V Kumar, R Becker.   

Abstract

The Alzheimer Disease Assessment Scale (ADAS) was administered to 61 patients with dementia of the Alzheimer type (DAT) and 52 elderly controls. The DAT group was subdivided into different severity levels of dementia based on scores from the Mini-Mental State Exam: very mild (greater than or equal to 24), mild (20 to 23), moderate (10 to 19), and severe (0 to 9). The mean scores on the ADAS Cognitive subscale for the four levels of dementia (very mild = 23.1 +/- 7.7, mild = 22.9 +/- 8.9, moderate = 38.6 +/- 9.8, severe = 54.8 +/- 7.6) were statistically different from one another (p less than 0.0001, except very mild vs. mild) and were significantly worse than the scores of the elderly control group (5.5 +/- 2.7, p less than 0.0001, ANOVA). Furthermore, the ADAS Cognitive subscale was highly effective in discriminating individual Alzheimer patients from elderly controls. The ADAS Cognitive score correctly classified 100% of the very mild group, 91% of the entire mild group, and 100% of the moderate and severe groups when a cutoff score of 2 SDs above the control group mean was used. Age and education had only minimal effects on the ADAS Cognitive score. The ADAS is a valuable screening test that only takes 30 min to administer and has utility in both early detection and staging of DAT.

Entities:  

Mesh:

Year:  1992        PMID: 1389084

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  10 in total

1.  Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Authors:  B Ravina; M Putt; A Siderowf; J T Farrar; M Gillespie; A Crawley; H H Fernandez; M M Trieschmann; S Reichwein; T Simuni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

2.  Comparing the effects of clinician and caregiver-administered lexical retrieval training for progressive anomia.

Authors:  Stephanie M Grasso; Kaleigh M Shuster; Maya L Henry
Journal:  Neuropsychol Rehabil       Date:  2017-06-30       Impact factor: 2.868

3.  Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.

Authors:  Mark D Lindner; John B Hogan; Donald B Hodges; Anitra F Orie; Ping Chen; Jason A Corsa; John E Leet; Kevin W Gillman; Gregory M Rose; Kelli M Jones; Valentin K Gribkoff
Journal:  Psychopharmacology (Berl)       Date:  2006-09-27       Impact factor: 4.530

4.  A study of medication-taking and unobtrusive, intelligent reminding.

Authors:  Tamara L Hayes; Kofi Cobbinah; Terry Dishongh; Jeffrey A Kaye; Janna Kimel; Michael Labhard; Todd Leen; Jay Lundell; Umut Ozertem; Misha Pavel; Matthai Philipose; Kevin Rhodes; Sengul Vurgun
Journal:  Telemed J E Health       Date:  2009-10       Impact factor: 3.536

5.  Dimensions of physical frailty and cognitive function in older adults with amnestic mild cognitive impairment.

Authors:  E L McGough; B B Cochrane; K C Pike; R G Logsdon; S M McCurry; L Teri
Journal:  Ann Phys Rehabil Med       Date:  2013-03-26

6.  Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.

Authors:  E G Visch Brink; W Van Rhee Temme; T Rietveld; J W M Krulder; F Van Harskamp; T J M Van der Cammen
Journal:  J Nutr Health Aging       Date:  2009-01       Impact factor: 4.075

7.  A Pilot Longitudinal Study on Cerebrospinal Fluid (CSF) Tau Protein in Alzheimer's Disease and Vascular Dementia.

Authors:  Haihong Wang; Tao Wang; Shixing Qian; Li Ba; Zhiguang Lin; Shifu Xiao
Journal:  Shanghai Arch Psychiatry       Date:  2016-10-25

8.  Resting-State Functional Connectivity Predicts Cognitive Impairment Related to Alzheimer's Disease.

Authors:  Qi Lin; Monica D Rosenberg; Kwangsun Yoo; Tiffany W Hsu; Thomas P O'Connell; Marvin M Chun
Journal:  Front Aging Neurosci       Date:  2018-04-13       Impact factor: 5.750

Review 9.  The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.

Authors:  Jacqueline K Kueper; Mark Speechley; Manuel Montero-Odasso
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Cognitive Health of Nonagenarians in Southern Italy: A Descriptive Analysis from a Cross-Sectional, Home-Based Pilot Study of Exceptional Longevity (Cilento Initiative on Aging Outcomes Or CIAO).

Authors:  Vincenzo Pizza; Paola Antonini; Rosella Marino; Giovanni D'Arena; Serena Grazia Lucibello; Marianna Rizzo; David A Brenner; Dilip V Jeste; Salvatore Di Somma
Journal:  Medicina (Kaunas)       Date:  2020-05-05       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.